Teva Pharmaceutical Industries Ltd (TEVA) 70.95

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Teva Pharmaceutical Industries Ltd (TEVA) 70.95 $TEVA

Fitch: Teva Remains on Watch Negative on Allergan Generics Acquisition
Business Wire - 6 mins ago
According to Fitch Ratings, the ratings of Teva Pharmaceutical Industries Limited (NYSE: TEVA) and its subsidiaries, including the 'BBB+' long-term Issuer Default Rating, remain on Rating Watch Negative, following its announcement that it will acquire the global generics business of Allergan plc (Allergan; NYSE: AGN) for $40.5 billion.
AGN: 337.53 (+10.55), TEVA: 70.95 (-1.05)

Stocks In Rebound Mode; Icon, Cadence Break Out
at Investor's Business Daily - 1 hr 1 min ago
Stocks stepped up rebound efforts and hit fresh session highs Tuesday afternoon. The major averages have recouped more than half of Monday's steep losses amid more earnings reports and mixed economic data. The S&P 500 led the pack with a 1% gain. On...
AGN: 337.53 (+10.55), BIDU: 164.64 (-33.04), MYL: 55.69 (-0.68), CDNS: 21.00 (+2.03), TEVA: 70.95 (-1.05), ICLR: 74.43 (+9.48)

Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 28, 9:50AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 181.70 (+2.81), AGN: 337.53 (+10.55), PPH: 73.81 (+0.62), EIS: 55.50 (+0.58), ISRA: 33.98 (+0.23), TEVA: 70.95 (-1.05)

Hikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 Billion
at The Street - Tue Jul 28, 9:46AM CDT
Jordan's Hikma Pharmceuticals is set to become the sixth-largest U.S. generic drug maker after an agreement to buy Boehringer Ingelheim's Columbus, Ohio-based Roxane Laboratories for about $2.65 billion.
AGN: 337.53 (+10.55), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05)

Teva Pharmaceutical Industries Up 15.4% Since SmarTrend Uptrend Call (TEVA)
Comtex SmarTrend(R) - Tue Jul 28, 9:43AM CDT
SmarTrend identified an Uptrend for Teva Pharmaceutical Industries (NASDAQ:TEVA) on July 9th, 2015 at $62.20. In approximately 3 weeks, Teva Pharmaceutical Industries has returned 15.42% as of today's recent price of $71.79.
TEVA: 70.95 (-1.05)

Will Teva Pharmaceutical (TEVA) Stock Rise Following BMO Capital Upgrade?
at The Street - Tue Jul 28, 9:39AM CDT
Teva Pharmaceutical (TEVA) had its rating increased to 'outperform' from 'market perform' at BMO Capital Markets this morning.
TEVA: 70.95 (-1.05)

Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.26 (+0.92), INVN: 13.54 (+0.65), COP: 52.86 (+2.21), TEVA: 70.95 (-1.05), TWTR: 36.27 (+1.57)

Watching Twitter for Moves at Teva and Biogen
at The Street - Tue Jul 28, 7:28AM CDT
Twitter sentiment predicts the big moves in two healthcare stocks-NYMX and BIIB.
BIIB: 317.62 (+8.19), TEVA: 70.95 (-1.05)

Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application
Business Wire - Tue Jul 28, 7:00AM CDT
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that it has successfully filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for reslizumab. Reslizumab is a humanized anti-interleukin-5 (IL-5) monoclonal antibody (mAb) for the treatment of inadequately controlled asthma in adult patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based regimen.
TEVA: 70.95 (-1.05)

Health Care & Industrials: Two ETFs Trading with Outsized Volume - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 5:00AM CDT
Heavier-than-normal volume put these health care and industrial ETFs in focus.
AGN: 337.53 (+10.55), SPY: 209.46 (+2.67), IYH: 161.82 (+2.60), QQQ: 111.32 (+1.14), DIA: 176.22 (+1.99), TEVA: 70.95 (-1.05), VIS: 103.43 (+1.91)

Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 337.53 (+10.55), QSR: 42.64 (+1.14), F: 14.88 (+0.33), QSR.TO: 55.09 (+0.88), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05), MHFI: 98.44 (-1.15)

Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 337.53 (+10.55), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05)

Look for Shares of Teva Pharmaceutical Industries to Potentially Pullback after Yesterday's 16.41% Rise
Comtex SmarTrend(R) - Mon Jul 27, 3:43PM CDT
Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $66.61 to a high of $72.15. Yesterday, the shares gained 16.4%, which took the trading range above the 3-day high of $63.36 on volume of 39.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TEVA: 70.95 (-1.05)

After Yesterday's Rally of 16.41% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 27, 3:42PM CDT
Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $66.61 to a high of $72.15. Yesterday, the shares gained 16.4%, which took the trading range above the 3-day high of $63.36 on volume of 39.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TEVA: 70.95 (-1.05)

Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 49.13 (-0.12), AGN: 337.53 (+10.55), AKRX: 46.81 (+0.65), SGNT: 25.43 (-0.05), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05)

Stocks Fall For Fifth Straight Session On China Woes
at Investor's Business Daily - Mon Jul 27, 3:39PM CDT
Stocks fell for the fifth straight session Monday as a sell-off in China's main index sparked fears of a slowdown in the world's second-biggest economy. The Nasdaq fell 1%, sliding below its 50-day moving average. The Dow Jones industrial average...
AGN: 337.53 (+10.55), NFX: 31.59 (+0.71), CYBR: 60.25 (+0.42), SOHU: 43.97 (+1.23), TEVA: 70.95 (-1.05), MRO: 21.51 (+0.82), JD: 32.40 (+0.25), PAYC: 31.41 (-0.19), BABA: 80.51 (-0.89)

Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 337.53 (+10.55), BIIB: 317.62 (+8.19), GILD: 112.96 (+2.42), TEVA: 70.95 (-1.05), TWTR: 36.28 (+1.58)

Teva and Restaurant Brands are big market movers
AP - Mon Jul 27, 3:25PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
QSR: 42.64 (+1.14), QSR.TO: 55.09 (+0.88), RJET: 3.19 (-0.58), MYL: 55.69 (-0.68), BECN: 33.21 (+0.51), TEVA: 70.95 (-1.05), WAB: 99.20 (+1.27)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Updated Category News Views 4

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

Continue Reading
EPR Fireworks, Schedule2.IT Enhance EMS Integration

Updated Category News Views 6

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Continue Reading
FSS Unveils AI Tool to Simplify Bankruptcy Cases

Updated Category News Views 5

AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....

Continue Reading
JennAir and Cosentino Introduce Seamless Kitchen Aesthetics

Updated Category News Views 4

It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...

Continue Reading
Crucial Insights for South GA Home Insurance Choices

Updated Category News Views 5

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

Continue Reading
Roof Replacement Timelines: Key Insights for PA Homeowners

Updated Category News Views 5

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

Continue Reading
Local Expertise in Real Estate: Key to Success?

Updated Category News Views 4

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Continue Reading
OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Updated Category News Views 4

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost

Updated Category News Views 4

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Continue Reading
University of Phoenix Grads Shine in Job Readiness

Updated Category News Views 4

University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...

Continue Reading

Top 5 Most Recently Viewed Articles

Lumen and Meta Collaborate to Enhance AI Network Solutions

Updated Category News Views 227

Introduction to the Partnership Lumen Technologies, Inc. (NYSE: LUMN) is making headlines as its shares see an uptick following an exciting announcement of a collaboration with Meta Platforms, Inc. (NASDAQ: META). This partnership aims to significantly bolster Meta’s network capacity to support its ambitious AI initiatives. Enhanced Network Capabilities The partnership...

Continue Reading
Arquus Achieves ISO 27001 Certification with MAGNA's Help

Updated Category News Views 114

Arquus Attains ISO 27001 Certification: A Game Changer Arquus, a visionary in defense and vehicle innovation, has reached an incredible milestone by securing the ISO 27001 information security management certification. This significant accomplishment has been made possible through the expert guidance of MAGNA, a recognized leader in cybersecurity services. Commitment to...

Continue Reading
Kenmare Resources' Performance Review and Projections Ahead

Updated Category News Views 259

Kenmare Resources Delivers Strong Results in 2024 Kenmare Resources plc, one of the leading global producers of titanium minerals and zircon, is poised to continue its success as it provides an overview of its production achievements and expectations for the upcoming year. Known for operating the Moma Titanium Minerals Mine, Kenmare's strategic advances and operational...

Continue Reading
Hermès Shows Impressive Growth in Q3 Revenue and Sales

Updated Category News Views 219

Strong Revenue Growth for Hermès International Hermès International continues to showcase its strength in the luxury market, achieving impressive revenue figures for the third quarter of 2024. The luxury powerhouse reported a consolidated revenue of €11.2 billion by the end of September, reflecting a notable increase of 14% at constant exchange rates and 11% at...

Continue Reading
ENLT Earnings Surprise: Traders Left Scrambling?

Updated Category News Views 133

Enlight Renewable Energy (NASDAQ:ENLT) just dropped its Q4 earnings on February 17, 2026, and the numbers hit like a freight train—EPS clocked in at $0.1, beating estimates by a whopping 225%. Sounds golden, right? But hang tight; there’s more to the story. Revenue Rises but Market Shakes On the surface, a revenue bump of $48.26 million from last year is great news....

Continue Reading